New DNA Sequencing Breakthrough Unlocks Precision in Genetic Disorders
New DNA Sequencing Breakthrough Unlocks Precision in Genetic Disorders
New DNA Sequencing Breakthrough Unlocks Precision in Genetic Disorders
A new long-read sequencing system has been developed to analyse DNA methylation with greater precision. Led by researchers T. Urakawa, A. Hattori, and Y. Ogiwara, the technology promises to improve diagnostic accuracy and support personalised medical treatments. The breakthrough could transform how scientists study genetic disorders linked to abnormal methylation patterns.
DNA methylation acts as a key regulator of gene activity, influencing how genes are expressed in the body. Abnormal changes in methylation—particularly in differentially methylated regions (DMRs)—have been tied to diseases like cancer and neurological conditions. Imprinting disorders, such as Prader-Willi and Angelman syndromes, often stem from incorrect methylation patterns.
The newly developed system overcomes the limits of older short-read technologies. By capturing data across longer DNA stretches, it provides clearer insights into methylation dynamics and structural variations. This approach requires advanced data processing but offers a more complete picture of epigenetic influences.
Researchers believe the system will help uncover the mechanisms behind imprinting disorders. Better understanding of these processes could lead to improved genetic counselling and targeted therapies for affected patients.
The long-read sequencing system marks a step forward in epigenetic research. It enables more accurate diagnosis and opens doors for tailored treatments in conditions driven by methylation errors. Clinicians and scientists may soon use this technology to refine genetic testing and patient care.